A “sample-to-answer” next generation newborn sequencing research workflow.

New method called ARTEMIS uses machine learning to shed light on human genome “dark matter” involved in cancer and other diseases.

More details on the IPSN catalytic grant fund can be found online.

All of Us Research Program.

The FDA granted the approval of Amtagvi to Iovance Biotherapeutics Inc.

Automating Thermo Fisher’s GMP-ready instruments using Multiply Labs’ robotic technology helps reduce costs and accelerates timelines.

New product.

Activating calcium channels leads to a deadly influx of calcium ions into tumor cells.

Pilot study by Children’s Hospital Los Angeles and City of Hope proposes a promising global, clinically applicable genomic assay for the diagnosis and treatment of this heterogeneous...

Partnership includes launch of new IDT xGen NGS products designed exclusively for Element’s AVITI System.